Key Findings:  The authors hypothesize that by inhibiting the enzymes responsible for the catabolism of endogenous cannabinoids locally, bladder concentrations of CBR2 agonists will increase, particularly 2-arachidonyl glycerol, resulting in a diminished inflammatory response.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Canada
Year of Pub:  2019
Cannabinoids Studied:  2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB2